Healthcare provider profile · identity verified

Sarah Moore, PA

Physician Assistant · MALONE, NY · NPI 1255883013

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	256	79
Gabapentin	Gabapentin	225	57
Rosuvastatin Calcium	Rosuvastatin Calcium	206	64
Omeprazole	Omeprazole	204	64
Levothyroxine Sodium	Levothyroxine Sodium	169	43
Lisinopril	Lisinopril	168	58
Losartan Potassium	Losartan Potassium	156	42
Metformin Hcl	Metformin Hcl	155	37
Metoprolol Succinate	Metoprolol Succinate	150	43
Pantoprazole Sodium	Pantoprazole Sodium	133	41
Hydrochlorothiazide	Hydrochlorothiazide	107	39
Potassium Chloride	Potassium Chloride	107	30
Sertraline Hcl	Sertraline Hcl	106	28
Amlodipine Besylate	Amlodipine Besylate	102	32
Simvastatin	Simvastatin	100	30
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	97	34
Montelukast Sodium	Montelukast Sodium	97	35
Duloxetine Hcl	Duloxetine Hcl	91	24
Albuterol Sulfate Hfa	Albuterol Sulfate	88	34
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	74	20
Furosemide	Furosemide	72	26
Metoprolol Tartrate	Metoprolol Tartrate	66	21
Mirtazapine	Mirtazapine	66	17
Fluticasone Propionate	Fluticasone Propionate	63	24
Ozempic	Semaglutide	62	14
Tramadol Hcl	Tramadol Hcl	60	12
Citalopram Hbr	Citalopram Hydrobromide	55	14
Famotidine	Famotidine	55	20
Allopurinol	Allopurinol	49	12
Eliquis	Apixaban	48	16
Farxiga	Dapagliflozin Propanediol	47	11
Trazodone Hcl	Trazodone Hcl	46	16
Nystatin	Nystatin	45	17
Tamsulosin Hcl	Tamsulosin Hcl	45	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	17
Buspirone Hcl	Buspirone Hcl	41	15
Ondansetron Odt	Ondansetron	41	12
Atenolol	Atenolol	40	12
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	40	13
Fluoxetine Hcl	Fluoxetine Hcl	40	14
Baclofen	Baclofen	38	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	11
Prednisone	Prednisone	36	21
Pregabalin	Pregabalin	36	suppressed
Torsemide	Torsemide	36	11
Finasteride	Finasteride	32	15
Spironolactone	Spironolactone	32	suppressed
Mounjaro	Tirzepatide	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Meclizine Hcl	Meclizine Hcl	29	12
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Nitroglycerin	Nitroglycerin	26	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Ramipril	Ramipril	25	suppressed
Varenicline Tartrate	Varenicline Tartrate	25	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	18
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	12
Azithromycin	Azithromycin	20	16
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Glipizide	Glipizide	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Topiramate	Topiramate	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Dapagliflozin	Dapagliflozin Propanediol	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Colchicine	Colchicine	13	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Metolazone	Metolazone	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Mexiletine Hcl	Mexiletine Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error